Autologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years

OBJECTIVE: To evaluate the efficacy and toxicity of autologous hematopoietic stem cell transplantation (AHSCT) for high-risk acute lymphoblastic leukemia (ALL). MATERIAL AND METHODS: Overall, 128 high-risk ALL patients at a median age of 26 years (range 18–56 years) at diagnosis received AHSCT betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Helbig, Grzegorz, Krawczyk-Kulis, Malgorzata, Kopera, Malgorzata, Jagoda, Krystyna, Rzepka, Patrycja, Majewska-Tessar, Aleksandra, Hejla, Marta, Kyrcz-Krzemien, Slawomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103509/
https://www.ncbi.nlm.nih.gov/pubmed/25045455
http://dx.doi.org/10.4084/MJHID.2014.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103509/
https://www.ncbi.nlm.nih.gov/pubmed/25045455
http://dx.doi.org/10.4084/MJHID.2014.047

Ejemplares similares